Self-administration of intravenous amphetamine: Effect of nucleus accumbens CCK(B) receptor activation on fixed-ratio responding

Psychopharmacology

Volumn 147, Issue 3, 1999, Pages 331-334

  Bush, D E A ^a   DeSousa, N J ^a   Vaccarino, Franco J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Amphetamine; CCK(B) receptor; Cholecystokinin; Dopamine; Reinforcement; Self administration

Indexed keywords

AMPHETAMINE; CHOLECYSTOKININ B RECEPTOR; DOPAMINE; PENTAGASTRIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOPAMINERGIC SYSTEM; DRUG SELF ADMINISTRATION; MALE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DEXTROAMPHETAMINE; INJECTIONS; INJECTIONS, INTRAVENOUS; MALE; NUCLEUS ACCUMBENS; PENTAGASTRIN; RATS; RATS, WISTAR; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

EID: 0033986954     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051176     Document Type: Article

References (22)

1. Caine SB, Lintz R, Koob GF (1993) Intravenous drug self-administration techniques in animals: In: Sahgal A (ed) Behavioural neuroscience: a practical approach, vol 2. Oxford University Press, Oxford, pp 117-142
2. Crawley JN, Hommer DW, Skirboll LR (1985a) Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat. Brain Res 335:337-341
3. Crawley JN, Stivers JA, Blumstein LK, Paul SM (1985b) Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence. J Neurosci 5:1972-1983
4. B receptor activation: a behavioral dissociation. Society for Neuroscience Abstracts 630.2, 23(2), 1620, New Orleans, LA
5. Ettenberg A (1989) Dopamine, neuroleptics and reinforced behavior. Neurosci Biobehav Rev 13:105-111
6. B receptor mechanisms to individual differences in amphetamine-induced locomotion. Pharmacol Biochem Behav 48:1019-1024
7. Hoebel BG, Monaco AP, Hernandez L, Aulisi EF, Stanley BG, Lenard L (1983) Self-injection of amphetamine directly into the brain. Psychopharmacology 81:158-163
8. Josselyn SA, Vaccarino FJ (1995) Interaction of CCKB receptors with amphetamine in responding for conditioned rewards. Peptides 16:959-964
9. Josselyn SA, Franco VP, Vaccarino FJ (1996) PD-135158, a CCKB receptor antagonist, microinjected into the nucleus accumbens and the expression of conditioned rewarded behavior. Neurosci Lett 209:85-88
10. Koob GF, Vaccarino FJ, Amalric M, Bloom FE (1987) Positive reinforcement properties of drugs: search for neural substrates. In: Engel J, Oreland L (eds) Brain reward systems and abuse. Raven Press, New York, pp 35-50
11. Lyness WH, Friedle NM, Moore KE (1979) Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration. Pharmacol Biochem Behav 11:553-556
12. Marshall FH, Barnes S, Hughes J, Woodruff GN, Hunter JC (1991) Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms. J Neurochem 56:917-922
13. Monaco AP, Hernandez L, Hoebel BG (1981) Nucleus accumbens: site of amphetamine self-injection: comparison with the lateral ventricle. In: Chronister RB, DeFrance JF (eds) The neurobiology of the nucleus accumbens. Haer Institute for Electrophysiology, Brunswick Maine, pp 338-342
14. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, New York
15. Vaccarino FJ (1994) Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors. Neurosci Biobehav Rev 18:207-214
16. Vaccarino FJ, Rankin J (1989) Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function. Behav Neurosci 103:831-836
17. Vaccarino FJ, Vaccarino AL (1989) Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: differential effects on brain stimulation reward. Neurosci Lett 97:151-156
18. Vaccarino FJ, Schiff BB, Glickman SE (1989) Biological view of reinforcement. In: Klein SB, Mowrer RR (eds) Contemporary learning theories. Lawrence Erlbaum, New Jersey, pp 111-142
19. Voigt M, Wang RY, Westfall TC (1986) Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vivo. J Pharmacol Exp Ther 237:147-153
20. White FJ, Wang RY (1984) Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons. Brain Res 300:161-166
21. Yokel RA (1987) Intravenous self-administration: response rates, the effects of pharmacological challenges, and drug preferences. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, Berlin Heidelberg New York, pp 1-33
22. Yokel RA, Piekens R (1974) Drug level of d- and l-amphetamine during intravenous self-administration. Psychopharmacologia 34:255-264